Moderna launches coronavirus vaccine Phase 3 trial

Moderna anticipates enrolling 30,000 U.S. participants.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.